Guardant Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Guardant Health, Inc. on January 11, 2026. The filing announces preliminary unaudited financial information for the quarter and full year ended December 31, 2025. The company is incorporated in Delaware and its common stock trades on The Nasdaq Global Select Market under the symbol "GH."
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It serves as a notification that this information is contained in a press release furnished as Exhibit 99.1, which is not included in the provided text.
Material Changes
No material changes versus prior periods are detailed in the text of this Form 8-K. The document references the announcement of preliminary results but does not quantify year-over-year or quarter-over-quarter performance.
Guidance, Outlook, and Risks
- Upcoming Presentation: The Company will present at the 2026 J.P. Morgan Healthcare Conference on January 12, 2026.
- Disclosure: The presentation materials will be posted on the Company's website under the "Investors" tab.
- Legal Status: The information in this report and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated January 11, 2026) for specific revenue, net income, and cash flow figures for Q4 and FY 2025.
- Access the presentation materials on the Guardant Health website following the January 12, 2026 J.P. Morgan Healthcare Conference for management commentary and outlook.
- Verify the unaudited nature of the preliminary financial data before making investment decisions.